Coronary Artery Disease
Conditions
Keywords
Optical coherence tomograhpy, registry, Coronary artery disease
Brief summary
The multicenter observational CLIMA registry has been conceived to explore correlation between OCT morphology of atherosclerotic plaques located in the left anterior descending artery with mid and long term clinical outcome.
Detailed description
Acute myocardial infarction (MI) is commonly caused by plaque ulceration and subsequent local thrombosis. Plaques that tend to rupture are typically characterized by a large superficial lipid pool, delimited by a thin fibrous cap and often exhibit local signs of inflammation. Such atherosclerotic lesions are commonly described as vulnerable plaques (1-4). Identification of these plaque features with imaging modalities is potentially a valid approach to identify patients at increased risk of M (5). Optical coherence tomography is capable of visualizing superficial plaque components at a high resolution (in the range of 10-15 microns) and can depict all the features of plaque vulnerability or thrombogenicity (6,7). The aim of the study is to relate presence of multiple OCT criteria of plaque vulnerability with following clinical events in a subset of coronary lesions. For this purpose all plaques in the proximal-mid portion of the left anterior descending artery will be evaluated with FD-OCT assessing the following criteria: * minimum lumen area (MLA) \<3.5 mm2: * fibrous cap minimum thickness \<75 µm: * lipid arc extension \>180°; * presence of macrophages;
Interventions
FD-OCT assessment of the native proximal-mid left descending artery during clinically indicated coronary angiography
Sponsors
Study design
Eligibility
Inclusion criteria
* Age \>18 years; * Patients with clinical indication to coronary angiography undergoing OCT evaluation of the left anterior descending artery regardless of the clinical syndrome; * Patients with at least 30 mm of naïve OCT-assessable proximal-mid left anterior descending artery; * Patient has been informed of the nature of the study and agrees to its provisions and has provided written informed consent to the procedure;
Exclusion criteria
* Female with childbearing potential or lactating; * Acute or chronic renal dysfunction (defined as creatinine greater than 2.0 mg/dl); * Advanced heart failure (NYHA III-IV) * Previous Coronary artery by-pass surgery * Previous stenting of proximal-mid left anterior descending artery with residual untreated segment \<30mm. * Co-morbidities that could interfere with completion of study procedures, or life expectancy less than 1 year; * Participating in another investigational drug or device trial that has not completed the primary endpoint or would interfere with the endpoints of this study; * Heavily calcified vessel and/or lesion which cannot be successfully imaged by OCT
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Major adverse cardiac events | 1-year | Composite of cardiac death and/or target vessel myocadial infarction |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Major adverse cardiac events | 3-year | Composite of cardiac death and/or target vessel myocadial infarction |
Other
| Measure | Time frame | Description |
|---|---|---|
| Predictive value of single OCT criteria of plaque vulnerability | 1-year and 3-year | Predictive value of minimum lumen area, fibrous cap thickness, lipid arc extension, presence of macrophages at the explored plaques |
Countries
Italy, Poland, Spain